Cargando…
Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer
Somatic mutations, which are associated with a certain rate of response to targeted therapies, are ubiquitously found in human non-small cell lung cancer (NSCLC). However, it is largely unknown which group of patients may benefit from the respective treatments targeting different somatic mutations....
Autores principales: | An, Yuzhi, Zhao, Zibo, Ou, Pengju, Wang, Guangchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058985/ https://www.ncbi.nlm.nih.gov/pubmed/26632716 http://dx.doi.org/10.1097/MD.0000000000002081 |
Ejemplares similares
-
LRIG2 expression and prognosis in non-small cell lung cancer
por: WANG, GUANGCHUAN, et al.
Publicado: (2014) -
Expression of miR-92a is associated with the prognosis in non-small cell lung cancer: An observation study
por: Huang, Yu-Fang, et al.
Publicado: (2022) -
Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
por: Lindquist, D, et al.
Publicado: (2014) -
Correlation of microRNA-335 expression level with clinical significance and prognosis in non-small cell lung cancer
por: Huo, Wen, et al.
Publicado: (2020) -
Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases
por: Huang, Zhangheng, et al.
Publicado: (2020)